Martin I. Freed serves as Executive at Solid Biosciences Inc., where they oversee executive responsibilities. Since joining the company, Martin I. Freed has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 28, 2021 involved transacting 3,333 shares valued at $127.5K.
Martin I. Freed currently holds 3,333 shares of Solid Biosciences Inc. (SLDB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Martin I. Freed has been a net neutral trader of SLDB stock. They have purchased $0 and sold $0 worth of shares.
Martin I. Freed's most recent insider trade was on Dec 28, 2021, when they sold 3,333 shares at $38.25 per share.
Get notified when new Form 4 filings are submitted
| 3,333 |
| $N/A |
| Discretionary |
| Jul 25, 2019 | SLDB | $250.0K | Award | 53,763 | $4.65 | Discretionary |